Prism Medico and Pharmacy Limited (BOM:512217)
India · Delayed Price · Currency is INR 29.78
+0.04 (0.13%)
At close: Sep 11, 2026
Prism Medico and Pharmacy Revenue
Prism Medico and Pharmacy had revenue of 8.55M INR in the twelve months ending June 30, 2026, down -60.39% year-over-year. In the fiscal year ending March 31, 2026, Prism Medico and Pharmacy had annual revenue of 24.43M with 286.68% growth.
Revenue (ttm)
8.55M
Revenue Growth
-60.39%
P/S Ratio
21.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
180.57M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 24.43M | 18.12M | 286.68% |
| Mar 31, 2025 | 6.32M | -22.93M | -78.40% |
| Apr 1, 2024 | 29.25M | 16.55M | 130.21% |
| Apr 1, 2023 | 12.71M | -71.73M | -84.95% |
| Apr 1, 2022 | 84.44M | -83.19M | -49.63% |
| Apr 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Regent Enterprises | 10.25B |
| Sonalis Consumer Products | 1.50B |
| Pulsar International | 1.45B |
| Yash Management & Satellite | 339.64M |
| H S India | 285.76M |
| EP Biocomposites | 136.40M |
| Cindrella Hotels | 112.51M |
| Cosyn | 112.27M |